KROS
Keros Therapeutics (KROS)
$78
About Keros Therapeutics (KROS)
Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.
Details
Daily high
$59.88
Daily low
$56.95
Price at open
$57.65
52 Week High
$73.00
52 Week Low
$27.02
Market cap
2.2B
Dividend yield
0.00%
Volume
224,704
Avg. volume
349,716
P/E ratio
-11.66
Keros Therapeutics News
Details
Daily high
$59.88
Daily low
$56.95
Price at open
$57.65
52 Week High
$73.00
52 Week Low
$27.02
Market cap
2.2B
Dividend yield
0.00%
Volume
224,704
Avg. volume
349,716
P/E ratio
-11.66